Issue Information
20 September 2019
20 September 2019
Rafal D. Mazur, David S. Goldberg – 20 September 2019 – The high efficacy of current hepatitis C virus (HCV) therapy and increased numbers of HCV‐infected deceased donors have changed the paradigm of HCV in liver transplantation (LT). Modeling studies have been performed to evaluate the optimal timing of HCV treatment (before versus after LT) in HCV‐infected patients and to assess the cost‐effectiveness of transplanting HCV‐infected livers into HCV− patients.
Weinan Qiu, Bin Wang, Yanan Gao, Yuan Tian, Meijie Tian, Yuanying Chen, Li Xu, Tso‐Pang Yao, Peng Li, Pengyuan Yang – 20 September 2019
20 September 2019
Chris C. Duszynski, V. Avati, A.P. Lapointe, F. Scholkmann, J.F. Dunn, M.G. Swain – 19 September 2019
Ben L. Da, Christopher Koh, Theo Heller – 18 September 2019
Ashish Kumar, Praveen Sharma, Anil Arora – 18 September 2019
Takashi Matsuzaka, Motoko Kuba, Saori Koyasu, Yuta Yamamoto, Kaori Motomura, Sundaram Arulmozhiraja, Hiroshi Ohno, Rahul Sharma, Takuya Shimura, Yuka Okajima, Song‐iee Han, Yuichi Aita, Yuhei Mizunoe, Yoshinori Osaki, Hitoshi Iwasaki, Shigeru Yatoh, Hiroaki Suzuki, Hirohito Sone, Yoshinori Takeuchi, Naoya Yahagi, Takafumi Miyamoto, Motohiro Sekiya, Yoshimi Nakagawa, Masatsugu Ema, Satoru Takahashi, Hiroaki Tokiwa, Hitoshi Shimano – 17 September 2019
Jing Fang, Yan‐Xiao Ji, Peng Zhang, Lin Cheng, Yue Chen, Jun Chen, Yanfang Su, Xu Cheng, Yan Zhang, Tianyu Li, Xuehai Zhu, Xiao‐Jing Zhang, Xiang Wei – 17 September 2019
Kristopher P. Croome, C. Burcin Taner – 17 September 2019